On Monday, July 2, GlaxoSmithKline agreed to a record-setting $3 billion criminal and civil settlement over drug misbranding.

In the nearly four years since GlaxoSmithKline looked to revamp the way it hires and pays for outside legal services, the pharmaceutical giant has saved tens of millions of dollars in legal fees.